Research Topics
| Guntram SchernthanerSummaryCountry: Austria Publications
| Collaborators
|
Detail Information
Publications
Increase in visfatin after weight loss induced by gastroplastic surgeryKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030 Vienna, Austria
Obesity (Silver Spring) 14:1886-9. 2006..To investigate whether visfatin concentrations are related to changes in body weight, this adipokine was measured in insulin-resistant severely obese patients before and after gastroplastic surgery...
[Success of blood pressure reduction in diabetic patients]G Schernthaner
Medizinische Abteilung Rudolfstiftung Wien, Wien, Germany
Dtsch Med Wochenschr 131:S247-51. 2006..While diuretics and ss-blockers have a prodiabetic effect, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers may prevent diabetes more effectively than the metabolically neutral calcium channel blockers...
Kidney disease in diabetologyGuntram Schernthaner
NDT, Head of the Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Nephrol Dial Transplant 22:703-7. 2007
GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patientsG Schernthaner
Rudolfstiftung Hospital, Vienna, Austria
Eur J Clin Invest 34:535-42. 2004..The European GUIDE study is the first large-scale head-to-head comparison of two sulphonylureas designed for once-daily administration used under conditions of everyday clinical practice...
[Progress in the prevention of type 2 diabetes]Guntram Schernthaner
I Medizinische Abteilung, Krankenhaus Rudolfstiftung, Wien, Osterreich
Wien Klin Wochenschr 115:745-57. 2003..Since many hypertensive patients are insulin-resistant and have an increased risk in developing type 2 diabetes, the protective effect of these classes of antihypertensive drugs might be explained by their antiinsulin-resistance effects...
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trialG Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, A 1030 Vienna, Austria
J Clin Endocrinol Metab 89:6068-76. 2004..HbA1c reduction is similar after pioglitazone and metformin monotherapies, but differences in FPG, plasma lipids, and adverse effects between the two compounds may influence decision-making in individual prescribers...
Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetesG Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030 Vienna, Austria
Diabetes Metab 36:389-94. 2010..This study aimed to assess the relative contributions of postprandial and fasting glucose concentrations to overall hyperglycaemia...
[Hypertension]Guntram Schernthaner
Medizinische Abteilung, Krankenanstalt der Stadt Wien, Wien, Osterreich
Acta Med Austriaca 31:166-7. 2004..The present article represents the recommendations of the Austrian Diabetes Association for the treatment of hypertension in diabetic patients according to current scientific evidence...
Is dyslipidaemia important if we control glycaemia?Guntram Schernthaner
Department of Medicine I, Rudolfstiftung Hospital Vienna, Juchgasse 25, A 1030 Vienna, Austria
Atheroscler Suppl 6:3-10. 2005..However, use of fibrates in combination with statins may pose an unacceptable risk of myopathy. Therefore, other strategies for combination therapy are needed to normalize lipids in patients with type 2 diabetes or metabolic syndrome...
Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?G Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Diabetes Obes Metab 12:1023-35. 2010....
Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factorsG Schernthaner
Department of Medicine, Rudolfstiftung Hospital, Vienna, Austria
Int J Clin Pract 63:912-29. 2009..As specific agonists of peroxisome proliferator-activated receptor-gamma, thiazolidinediones have also demonstrated protective effects on a variety of atherosclerosis biomarkers and surrogate measures of cardiovascular disease...
Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesityGerit Holger Schernthaner
Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria
Obes Surg 16:709-15. 2006....
Bariatric surgery in patients with morbid obesity and type 2 diabetesGuntram Schernthaner
Department of Medicine I, Rudolfstiftung Hospital Vienna, Juchgasse 25, A-1030 Vienna, Austria
Diabetes Care 31:S297-302. 2008
Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGARGuntram Schernthaner
Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria
Wien Med Wochenschr 160:8-19. 2010..Future ongoing outcome studies in more than 50,000 patients will clarify whether new antidiabetic drugs--not inducing hypoglycemia or weight gain--will further improve the prognosis of T2DM patients...
Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight lossJohanna Maria Brix
Department of Medicine 1, Rudolfstiftung Hospital, Vienna, Juchgasse 25, Vienna, Austria
J Clin Endocrinol Metab 95:4877-81. 2010..The liver-secreted protein Fetuin-A is elevated in insulin resistance, is an independent predictor of type 2 diabetes and is associated with atherosclerosis...
YKL-40 is elevated in morbidly obese patients and declines after weight lossMoritz Hempen
Department of Medicine II, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Obes Surg 19:1557-63. 2009..The present study aims to study the level of YKL-40 in MO patients before and after weight loss as well as to investigate the relationship between YKL-40, IR, MCP-1, and obesity...
Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistanceGeorg Schaller
Department of Internal Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030, and Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Obes Surg 19:351-6. 2009....
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patientsH P Kopp
Department of Medicine 1, Rudolfstiftung Hospital, Juchgasse 25, A 1030 Vienna, Austria
Arterioscler Thromb Vasc Biol 23:1042-7. 2003..Elevated levels of C-reactive protein (CRP) and interleukin-6 (IL-6), indicating chronic subclinical inflammation, have been associated with features of the IRS and incident cardiovascular disease...
Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular diseaseSimon Brunner
Department of Ophthalmology, Rudolf Foundation Clinic, Vienna, Austria
Invest Ophthalmol Vis Sci 52:4655-62. 2011....
Thrombin generation in type 2 diabetes with albuminuria and macrovascular diseaseLeyla Ay
Department of Internal Medicine I, Rudolfstiftung Hospital Vienna, Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 42:470-7. 2012..Albuminuria is an indicator of cardiovascular morbidity and mortality in patients with type 2 diabetic mellitus (T2DM)...
Relationship of androgens to insulin resistance and chronic inflammation in morbidly obese premenopausal women: studies before and after vertical banded gastroplastyHans Peter Kopp
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Obes Surg 16:1214-20. 2006....
YKL-40 concentrations are not elevated in gestational diabetesGeorg Schaller
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Eur J Clin Invest 40:339-43. 2010..The involvement of inflammatory mechanisms in GDM remains unclear. YKL-40 is a novel inflammatory marker that has been recently found to be associated with type 2 diabetes. This is the first study to investigate YKL-40 in GDM...
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetesKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030 Vienna, Austria
Atherosclerosis 189:236-40. 2006..Recent reports suggest a relationship between tHcy and ADMA. To evaluate the connection between ADMA and tHcy and macrovascular disease, we determined both risk factors in T2DM patients with and without macrovascular disease...
Circulating levels of MCP-1 are increased in women with gestational diabetesKatharina Klein
Department of Obstetrics and Feto maternal Medicine, Medical University of Vienna, Vienna, Austria
Prenat Diagn 28:845-51. 2008..We investigated whether gestational diabetes mellitus is associated with monocyte-chemoattractant-protein-1 (MCP-1) and soluble CD40 ligand (sCD40L), the functional relevant proteins in the inflammatory process...
Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo dataSimon Brunner
Department of Ophthalmology, Rudolf Foundation Clinic Vienna, Vienna, Austria
Invest Ophthalmol Vis Sci 50:392-8. 2009..To investigate vasculogenic circulating progenitor cells (CPCs), endothelial progenitor cells (EPCs), and mature EPCs in patients with type 1 diabetes mellitus (T1DM) with or without diabetic retinopathy (DR)...
Organ protection in the secondary prevention of type 2 diabetesGuntram Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Drugs Today (Barc) 42:17-23. 2006..Pioglitazone has furthermore demonstrated numerous antiatherogenic effects in clinical and preclinical investigations...
YKL-40 in type 2 diabetic patients with different levels of albuminuriaJohanna M Brix
Rudolfstiftung Hospital Vienna, Medicine I, Vienna, Austria
Eur J Clin Invest 41:589-96. 2011..YKL-40 is also associated with both and elevated in nondiabetic vascular patients. We investigated YKL-40 and its association with vascular disease in type 2 diabetic patients with albuminuria...
High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetesKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Transl Res 153:199-203. 2009..It is unlikely that HMW adiponectin has significant vasoprotective effects in these patients...
Renal function but not asymmetric dimethylarginine is independently associated with retinopathy in type 2 diabetesKatarzyna Krzyzanowska
Internal Medicine 1, Rudolfstiftung Hospital, 1030 Vienna, Austria
Cardiol Res Pract 2011:260191. 2011..006). Conclusions. These findings indicate an association between ADMA and DR in T2DM independent of macrovascular disease. This relationship is modified by GFR, the only parameter significantly related to DR in multivariate analysis...
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetesKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030 Vienna, Austria
Diabetes Care 30:1834-9. 2007..We hypothesized that ADMA predicts cardiovascular events and enhances risk prediction independent of established risk markers in patients with type 2 diabetes...
ADMA, cardiovascular disease and diabetesKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Diabetes Res Clin Pract 82:S122-6. 2008..In addition, ADMA might not only be a risk marker but also a causative factor for cardiovascular disease. This review summarizes the literature on the relationship between ADMA, cardiovascular disease and diabetes...
Increased visfatin concentrations in women with gestational diabetes mellitusKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Clin Sci (Lond) 110:605-9. 2006..001). In conclusion, visfatin is elevated in women with GDM and increases during the course of pregnancy as well as after delivery. Furthermore, visfatin shows no association with insulin and leptin in women with GDM...
[Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP)]Michael Roden
1 Med Abteilung, Hanusch Krankenhaus, Karl Landsteiner Institut für Endokrinologie und Stoffwechsel, Wien, Austria
Wien Klin Wochenschr 120:558-65. 2008..With regard to national and international guidelines, there is still a need to improve the clinical practice of lowering LDL-C for secondary prevention in high risk patients in Austria...
Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese womenKatarzyna Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, 1030 Vienna, Austria
J Clin Endocrinol Metab 89:6277-81. 2004..The decrease of highly elevated ADMA concentrations in morbidly obese patients is paralleled by improvement of parameters associated with the metabolic syndrome after weight loss...
Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial diseaseDavid Peter Lorant
Department of Medicine II, Medical University of Vienna, Vienna, Austria
Diabetes Care 34:156-61. 2011..In contrast, elevated fetuin-A is associated with cardiovascular events in non-renal patients. We investigated fetuin-A in patients with type 2 diabetes and peripheral arterial disease (PAD)...
Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70G Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Horm Metab Res 36:188-93. 2004..This study was designed to compare metabolic control with three daily injections of Humalog Mix50 or premixed human insulin 30/70 (30 % regular/70 % NPH) twice daily in accordance with normal prescription practice...
Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgeryG H Schernthaner
Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 36:395-401. 2006..As morbid obesity is closely associated with chronic inflammation and insulin resistance (IR), it was of interest to study sCD40L in patients with morbid obesity before and after massive weight loss induced by bariatric surgery...
[Diabetes Care Austria 2009: registry for type 2 diabetic patients in general practitioners' ordinations in Austria]Bernhard Ludvik
Klinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Austria
Wien Klin Wochenschr 124:69-77. 2012..2%. An insulin therapy was initialised late, but was nevertheless effective as shown by comparable HbA1c values in patients with a diabetes duration of 4 to more than 15 years...
[The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus]Bernhard Ludvik
Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Austria
Wien Klin Wochenschr 121:473-82. 2009..This position paper summarises up the current evidence concerning this subject...
Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic interventionGerit-Holger Schernthaner
Department of Internal Medicine II, Division of Angiology, Medical University Vienna, Austria
Scand J Clin Lab Invest Suppl 240:30-40. 2005....
The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary-failure to sulfonylureas. A five year follow-up studyS Kudlacek
I. Med. Abteilung der Krankenanstalt Rudolfstiftung, II. Med. Univ. Klinik, Wien, Austria
Horm Metab Res 24:478-83. 1992..Furthermore, small increases of plasma creatinine from 88.4 microM to 115 microM, as well as systolic (19.3 kPa to 20.7 kPa) and diastolic (10.7 kPa to 11.3 kPa) blood pressures were observed.(ABSTRACT TRUNCATED AT 250 WORDS)..
YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetesKlaudija Batinic
Division of Pediatric Cardiology, University Zurich, Switzerland
Atherosclerosis 222:557-63. 2012..Experimental in vivo and in vitro data suggest a role of YKL-40 in tissue remodeling. A disease modulating potency of YKL-40 was not investigated in peripheral arterial disease (PAD)...
Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effectsGuntram Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Metabolism 52:29-34. 2003..In addition, gliclazide MR shows the ability to inhibit key mechanisms in diabetic angiopathy, independently of glycemic control...
Kidney disease in diabetology: lessons from 2007Guntram Schernthaner
Guntram Schernthaner, Rudolfstiftung Hospital, A-1030, Juchgasse 25, Vienna, Austria
Nephrol Dial Transplant 23:1112-5. 2008
Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegalyJulia Szendroedi
1st Med Department and Karl Landsteiner Institute for Endocrinology and Metabolism, Hanusch Hospital, Vienna, Austria
PLoS ONE 3:e3958. 2008..As growth hormone (GH) excess can reduce insulin sensitivity, we examined the impact of previous acromegaly (AM) on glucose metabolism, lipid storage and muscular ATP turnover...
Thrombin generation in morbid obesity: significant reduction after weight lossL Ay
Department of Internal Medicine I, Rudolfstiftung Hospital Vienna, Austria
J Thromb Haemost 8:759-65. 2010..Patients with morbid obesity (MO; body mass index > 40 kg m(-2)) suffer from an increased risk of cardiovascular disease, stroke, venous thromboembolism and all-cause mortality...
Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetesK Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, 1030, Vienna, Austria
Diabetologia 51:1115-22. 2008..Retinol-binding protein 4 (RBP4) could be related to insulin resistance. We hypothesised that RBP4 is elevated in gestational diabetes...
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese womenH P Kopp
Department of Medicine 1, Rudolfstiftung Hospital Vienna, Austria
Int J Obes (Lond) 29:766-71. 2005....
High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarismK Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Exp Clin Endocrinol Diabetes 113:430-4. 2005..The high prevalence of nocturnal non-dipping and glucose intolerance detected in this cohort might contribute to the increased cardiovascular risk of hypopituitary patients...
Improved metabolic control decreases platelet activation markers in patients with type-2 diabetesN Eibl
Rudolfstiftung Hospital, Vienna, Austria
Eur J Clin Invest 34:205-9. 2004..Our study attempts to clarify the effect of improved metabolic control on platelet activation markers in patients with type-2 diabetes...
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuriaK Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Medical University Vienna, Austria
Diabet Med 24:81-6. 2007..To determine the relationship between ADMA, renal albumin excretion rate (AER) and cardiovascular risk, we studied 103 T2DM patients...
Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiencyK Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030 Vienna, Austria
Eur J Clin Invest 35:208-13. 2005..We studied the concentrations of ADMA in hypopituitary patients with and without growth hormone deficiency (GHD) and in healthy subjects...
Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetesG Schernthaner
Department of Internal Medicine, Rudolfstitung Hospital, Vienna, Austria
Diabet Med 21:279-84. 2004..Administration of bolus insulin after eating may be a useful therapeutic option for some patients. This 6-month, crossover study compared metabolic effects of routine use of preprandial vs. postprandial injection of bolus insulin lispro...
Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazoneK Krzyzanowska
Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Horm Metab Res 39:769-72. 2007..CRP and resistin were not affected by rosiglitazone or FFAs. The acute increase in circulating adiponectin concentrations during acutely elevated FFA depends on PPAR gamma activation in healthy subjects...
[Angiotensin II type-1 receptor antagonists and diabetes mellitus]C Schnack
I Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Juchgasse 25, A 1030 Wien
Wien Med Wochenschr 151:165-8. 2001....
A serine/alanine polymorphism in the nucleotide-binding fold-2 of the sulphonylurea receptor-1 (S1369A) is associated with enhanced glucose-induced insulin secretion during pregnancyW Krugluger
Institute of Clinical Chemistry, Municipal Hospital Rudolfstiftung, Vienna, Austria
J Inherit Metab Dis 23:705-12. 2000..01, p=0.9). From our data we conclude that in PW with the alanine substitution in the NBF-2 region, the insulin response of the pancreatic beta-cell after glucose intake is enhanced and does not correlate with actual BG levels...
Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitusS Equiluz-Bruck
Department of Medicine I, Rudolfstiftung Hospital Vienna, Austria
Am J Hypertens 9:1139-43. 1996....
Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study)H Abrahamian
City Hospital Vienna Lainz, 3rd Medical Department, Vienna, Austria
Horm Metab Res 37:684-9. 2005....
Low levels of Sex-Hormone-Binding Globulin predict insulin requirement in patients with gestational diabetes mellitusH P Kopp
Department of Medicine 1, Rudolfstiftung Hospital, Juchgasse 25, A 1030 Vienna, Austria
Exp Clin Endocrinol Diabetes 109:365-9. 2001..30; p <0.01). In summary, we found significantly lower levels of SHBG in patients with GDM, especially in those who developed severe GDM and required insulin therapy during the last months of pregnancy...
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisG Schernthaner
Department of Medicine I, Rudolfstiftung Hospital Vienna, Juchgasse 25, 1030, Vienna, Austria
Diabetologia 53:1258-69. 2010..This paper critically assesses the basis of the ADA/EASD algorithm and the resulting tiers of treatment options...
[Diabetic nephropathy-update 2012]Martin Auinger
3 Medizinische Abteilung, Krankenhaus Hietzing der Stadt Wien, und Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Wien, Osterreich
Wien Klin Wochenschr 124:42-9. 2012..The present article represents the recommendations of the Austrian Diabetes Association and the Austrian Society for Nephrology for the prevention and treatment of diabetic nephropathy...
The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European womenA Kautzky-Willer
Department of Endocrinology and Metabolism, Medical University of Vienna, Wahringer Gurtel 18 20, Vienna, Austria
J Clin Endocrinol Metab 93:1689-95. 2008....
[Antihypertensive therapy in diabetes mellitus : 2012 guidelines of the Austrian diabetes association]Guntram Schernthaner
1 Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Wien, Osterreich
Wien Klin Wochenschr 124:23-7. 2012..Most patients with diabetes mellitus need antihypertensive combination therapies, whereby ACE-inhibitors or Angiotensin-II receptor antagonists should be first line drugs...
Impaired primary immune response in type-1 diabetes: results from a controlled vaccination studyNicole Eibl
Krankenanstalt Rudolfstiftung, 1. Medizinische Abteilung, Juchgasse 25, A-1030 Vienna, Austria
Clin Immunol 103:249-59. 2002....
Compression of kidneys in Erdheim-Chester disease of retroperitoneum: Open surgical approachThomas Florian Wimpissinger
Department of Urology and Ludwig Boltzmann Institute for Extracorporeal Lithotripsy and Endourology, Rudolfstiftung Hospital, Vienna, Austria
Urology 65:798. 2005..After 3 years of follow-up, we have concluded that the open surgical approach is an option in the management of renal complications in Erdheim-Chester disease...
Enhanced growth hormone responses to growth hormone releasing hormone in male type I diabetic patientsP Pietschmann
, Vienna, Austria
Horm Metab Res 23:379-82. 1991..The absence of an effect of sex on GHRH stimulated GH responses in type I diabetes mellitus provides further evidence of an abnormal GH secretion in this disorder...
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive diseaseG H Schernthaner
Department of Internal Medicine II, Medical University of Vienna, and Department of Internal Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Eur J Clin Invest 36:333-9. 2006..Although peripheral arterial occlusive disease (PAOD) is significantly associated with elevated homocysteine levels, the clinical relevance of hyperhomocysteinaemia for the prevention and progression of PAOD is still unknown...
Increased growth hormone responses to growth hormone releasing hormone and thyrotropin releasing hormone in patients with metastatic testicular cancerP Pietschmann
, Wien, Austria
Horm Metab Res 22:109-13. 1990..Our data suggest an alteration of hypothalamic and/or pituitary regulation of GH secretion in patients with metastatic testicular cancer...
Progress in the immunointervention of type-1 diabetes mellitusG Schernthaner
Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria
Horm Metab Res 27:547-54. 1995..e. Coxsackie virus protein P2-c) could be adopted. If all these interventions are not effective in the long term run, research should be concentrated on molecular approaches after improvement in gene transfer technology...
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney diseaseChristian A Schneider
Facharzt für Innere Medizin Kardiologie Klinik III für Innere Medizin, Zimmer 0, C, 329 Universität zu Köln Kerpener Strasse 68, 50937 Koln, Germany
J Am Soc Nephrol 19:182-7. 2008..Patients who had CKD and were treated with pioglitazone were less likely to reach a composite end point of all-cause death, MI, and stroke, independent of the severity of renal impairment...
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adultsSinead Brophy
School of Medicine, Swansea University, Swansea SA2 8PP, UK
Diabetes Care 31:439-41. 2008..Latent autoimmune diabetes in adults is type 1 diabetes presenting as non-insulin dependent diabetes. One feature of the selection criteria is time independent of insulin treatment. We examine the validity of this criterion...
Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatmentDennis Heutling
Department of Endocrinology and Metabolism, Otto von Guericke University, D 39120 Magdeburg, Germany
J Clin Endocrinol Metab 93:82-90. 2008..The endogenous nitric oxide synthase inhibitor asymmetrical dimethyl-L-arginine (ADMA) is associated with atherosclerosis and represents an independent marker for cardiovascular morbidity and mortality...
Case studies: reducing risk in patients with diabetesMichel Komajda
Institut de Cardiologie, Hopital Pitie-Salpetriere, Universite Pierre et Marie Curie, Paris, France
Drugs Today (Barc) 42:37-41. 2006
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialJohn A Dormandy
Department of Clinical Vascular Research, Ingelby House, St Georges Hospital, Blackshaw Road, London SW17 0QT, UK
Lancet 366:1279-89. 2005..Our aim, therefore, was to ascertain whether pioglitazone reduces macrovascular morbidity and mortality in high-risk patients with type 2 diabetes...
Weight loss reduces tissue factor in morbidly obese patientsChristoph W Kopp
2nd Department of Medicine, Angiology Division, University of Vienna, General Hospital AKH, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Obes Res 11:950-6. 2003..To investigate the tissue factor (TF) pathway in clinical obesity and associated metabolic syndrome...
Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)Robert Wilcox
Department of Cardiovascular Medicine, Queen s Medical Centre, University Hospital, Nottingham, UK
Stroke 38:865-73. 2007..Diabetes is an important risk factor for stroke. We conducted analyses in patients who had entered the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive) with a history of stroke or without stroke...
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Lars Ryden
Department of Cardiology, Karolinska University Hospital, Sweden
Eur Heart J 28:88-136. 2007
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsNish Chaturvedi
International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College Healthcare NHS Trust, London, UK
Lancet 372:1394-402. 2008..We therefore designed the DIabetic REtinopathy Candesartan Trials (DIRECT) Programme to assess whether candesartan could reduce the incidence and progression of retinopathy in type 1 diabetes...
Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cellsMartin Spatz
Biomedizinische ForschungsgmbH, Schwarzspanierstrasse 15 1 19, A 1090 Vienna, Austria
Cell Immunol 221:15-26. 2003....
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie
Department of Ophthalmology, Odense University Hospital, Odense, Denmark
Lancet 372:1385-93. 2008..Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow the progression and, secondly, induce regression of retinopathy in people with type 2 diabetes...
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsMarc A Pohl
Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A51, Cleveland, OH 44195, USA
J Am Soc Nephrol 16:3027-37. 2005..There was no correlation between diastolic BP and renal outcomes. We recommend a SBP target between 120 and 130 mmHg, in conjunction with blockade of the renin-angiotensin system, in patients with type 2 diabetic nephropathy...
Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight lossThomas Reinehr
Vestische Hospital for Children and Adolescents Datteln, University of Witten Herdecke, Dr F Steiner Str 5, 45711 Datteln, Germany
Obes Surg 17:1571-7. 2007..The aim of this study was to analyze the relationships between fasting PYY, GLP-1, and weight status in morbidly obese patients before and after surgically induced weight loss...
